Abstract
PRIMARY TRACK
Guideline development
SECONDARY TRACK
Guideline development groups/panels/committees
BACKGROUND (INTRODUCTION)
Most medical societies recognize the importance of trusted guidelines as a foundation for health care decisions, but few have the expertise to independently produce valid, evidence-based guidelines that meet the needs of their membership. Despite the challenges of guideline development, many medical societies are unaware of support and resources available through the Guidelines International Network (GIN). The purpose of this invited parallel session is to explore the synergy of combining the content expertise of medical societies with the methodological expertise and networking opportunities of GIN.
LEARNING OBJECTIVES (TRAINING GOALS)
Learn how a medical society can benefit from participating in GIN. Recognize GIN resources and networking opportunities that can enhance the ability of a medical society to produce valid guidelines, regardless of their current expertise in guideline methodology. Understand how GIN can assist medical societies and what the societies can provide in return to assist GIN.
DESCRIPTION
This invited parallel session will explore opportunities for successful collaboration between GIN and medical societies. The target audience is members and staff of medical societies interested in learning how involvement with GIN can improve their ability to develop, implement, and assess guidelines of relevance to their membership.
David Nielsen, EVP and CEO of the AAO–HNS, will describe how a society with limited guideline experience developed a thriving program through effective collaboration with GIN and the Cochrane Collaboration. Conversely, David Gutterman, president-elect of the ACCP, will demonstrate how a society with a well-established guideline program can work with GIN to improve and streamline their processes.
The needs, in general, of medical specialty societies relating to guideline development will be discussed by Norman Kahn, EVP and CEO of the CMSS. A critical priority of CMSS, which includes more than 40 members, is to help specialty societies migrate to a culture of quality improvement and performance measurement. In this regard, Jako Burgers, past chair of the GIN board of trustees, will summarize how GIN can help medical societies with guideline development and how the societies can assist GIN. Time is allotted for audience questions.
TARGET AUDIENCE(S)
Medical society members and staff Guideline developer Guideline implementer Developer of guideline-based products Quality improvement manager/facilitator